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Summary A rat thyroid cancer cell line, FRTC, was established from the normal rat thyroid cell line, FRTL-5. FRTL-5 cells were cultured in
vitro with N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) for 4 days and were transplanted intraperitoneally into Fisher rats. Disseminated
tumour formation in the peritoneum was found in ten out of ten rats in which MDP-treated FRTL-5 cells were transplanted. Colloid-like
structures stained with anti-thyroglobulin (Tg) antibodies were observed in the tumours. On the other hand, no tumour was found in any of the
rats in which untreated FRTL-5 cells were transplanted. No morphological changes were observed in FRTL-5 cells after long-term in vitro
culture in the presence of MDP. MDP had no effect on thymidine incorporation, the production of cAMP or the expression of c-myc in FRTL-5
cells in vitro. Cells from the tumour (FRTC) secreted Tg in vitro and expressed Tg, thyroid peroxidase (TPO) and thyrotropin (TSH) receptor
mRNA. The expression of TSH receptor mRNA increased in FRTC cells after TSH stimulation. FRTC cells produced cAMP in response to
TSH stimulation in a dose-dependent manner. However, the growth of FRTC cells was TSH independent. Expression of c-myc and c-fos
was observed in FRTC cells in vivo as well as in vitro. FRTC cells formed tumours in Fisher rats when transplanted subcutaneously. FRTC
cells have several characteristics of differentiated thyroid cancer cells and may provide a good model for the study of human differentiated
thyroid cancers.
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Previous studies have shown that thyroid tumours can be produced
in vivo in rats by feeding thiouracil (Wollman, 1963) or 131'
followed by a low-iodine diet (Volpert and Prezyna, 1977).
Recently, there have been several reports regarding the in vitro
generation of mutant cells from the normal rat thyroid cell line,
FRTL-5 (Ambesi-Impiombato et al, 1980). FRTL-5 has many
characteristics of thyroid epithelial cells, such as thyroglobulin
(Tg) synthesis, iodine concentration and thyroid-stimulating
hormone (TSH)-dependent cell growth. However, after the estab-
lishment of mutated FRTL-5 cells by various methods, such as
chemical mutagenesis (Tramontano et al, 1986a; Sugawa et al,
1989), transformation with virus, oncogenes or human TSH
receptor cDNA (Fusco et al, 1981, 1987; Ferrentino et al, 1984;
Berlingieri et al, 1990; Derwahl et al, 1992) or cellular cloning
(Endo et al, 1990), many of these cells have lost TSH-dependent
growth and their differentiation markers. On the otherhand, human
thyroid cancers are often characterized by well-differentiated
features that include Tg production and expression of Tg, thyroid
peroxidase (TPO) and TSH receptor mRNA. (Brabant et al, 1991;
Ohta et al, 1991).
N-acetyl-muramyl-L-alanyl-D-isoglutamine (hereafter referred
to as MDP for muramyl dipeptide) has been shown to have the
minimal structure required for the adjuvant activity of mycobac-
teria as demonstrated by stimulation of enhanced immune
responses in vivo and in vitro (Ellouz et al, 1974; Lefrancier et al,
1977; Specter et al, 1977). During our preliminary study using
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MDP as adjuvant in the co-culture of FRTL-5 cells and Fisher rat
spleen cells in vitro, we have found that these cells formed
tumours when they were transplanted in Fisher rats. We then
confirmed that the tumour was ofepithelial cell origin, and spleen
cells were not necessary to induce the tumour. We report here the
MDP-mediated in vivo transformation of FRTL-5 cells to cancer
cells (FRTC). FRTC retained various characteristics of a well-
differentiated thyroid carcinoma. FRTC responded to TSH
stimulation to produce Tg and cAMP, and expressed Tg, TPO
and TSH receptor mRNA. However, the growth of FRTC was
independent ofTSH.
MATERIALS AND METHODS
Cell culture
FRTL-5 cells (donated by Dr Kohn, NIH, in 1987) were main-
tained in Ham's F-12 medium supplemented with 5% calf serum
and six hormones (6H medium), as described previously (Ambesi-
Impiombato et al, 1980). FRTL-5 cells were cultured in 6H
medium in the presence or absence of 20 mg 1-' MDP (Sigma, St
Louis, USA) for 4 days at 37°C in 5% carbon dioxide. Cells were
harvested after dispase digestion and 3 x 105 cells were injected
intraperitoneally into Fisher rats. One month after the transplanta-
tion, disseminated peritoneal tumour was collected and digested
with collagenase. Cells were then washed, suspended in the
6H medium and cultured in a plastic flask (Nunc, Roskilde,
Denmark). As we found that the proliferation of these cells
(FRTC) was independent of six hormones, Ham's F-12 medium
supplemented only with 5% calf serum was used to maintain
FRTC cells. Unless otherwise stated, FRTC cells of the third
generation were used for the experiments.
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Figure 1 A Histological examination of peritoneal tumour developed in rats
injected with MDP-treated FRTL-5 cells. Bar=50 gm. B Colloid-like structures
in the tumour (arrow). Bar=100 ,um
Figure 2 A Immunoreactive Tg was detected in the colloid-like structures in
the tumour. Bar=50 gm. B The thyroid follicles from the same rat stained with
anti-Tg antibodies. Bar=50 gm
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Table 1 Effect of TSH on the proliferation of FRTC cells
TSH (mU 1-')
0 0.01 0.1 1 10
[3H]TdR uptake 100a 105±4 108±6 89±8 83±5
(% of control)
aThe basal uptake was 6256 ± 462 c.p.m. (mean ± s.d. of quadruplicate
cultures). The result is representative of three different experiments.
N
Figure 3 Tumour formation in a Fisher rat after subcutaneous transplantation
of FRTC cells
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Figure 4 cAMP production in FRTL-5 (O) and FRTC (0) cells after TSH
stimulation
Tg measurement and staining
Culture supernatants from 1 x 105 FRTL-5 and FRTC cells stimu-
lated with various amounts of TSH for 24 h were collected. Tg in
the supernatants was measured by enzyme-linked immunosorbent
assay (ELISA) as described previously (Yanagisawa et al, 1986;
litaka et al, 1991). Antibodies to ratTg were prepared in the rabbit.
Sections of paraffin-embedded tumour were stained with biotin-
labelled anti-rat Tg antibodies and Vectastain ABC kit (Vector
Laboratories, Burlingame, USA) according to the manufacturer's
instructions. Control antibodies to rat lymphocyte surface antigens
(OX6, OX8 and W3/25) were obtained from Harlan Sera-Lab
(Crawley Down, UK).
Responses to various agents
FRTL-5 cells (1 x 105 cells per well) were cultured in 5H medium
(without TSH) supplemented with 5% calfserum for 5 days before
Table 2 The effect of various stimuli on the proliferation of FRTC cells
Stimulus [3H]TdR uptake (% of control)
None 1QQa
TSH (1 mU 1-') 87.2 ± 4.4
IGF-1 (10 nmol 1-') 114.2 ± 4.9
EGF (10 tg I-') 89.1 ± 2.9
aThe basal uptake was 10 418±204 c.p.m. (mean ± s.d. of quadruplicate
cultures). The result is representative of three different experiments.
exposure to various stimuli. Recombinant insulin-like growth
factor (IGF)-l and mouse epidermnal growth factor (EGF) were
obtained from Toyobo (Osaka, Japan) and Sigma, respectively.
Cells were stimulated with various stimuli for 24 h. Proliferation
ofFRTL-5 and FRTC cells was estimated by [3H]thymidine (TdR,
Amersham, Tokyo, Japan) uptake for 3 h as described previously
(litaka et al, 1991). Cell proliferation was also estimated by the
incorporation ofcrystal violet andphotometric analysis asreported
previously (Flick and Gifford, 1984). The cAMP content ofsuper-
natants after 3 h exposure to various stimuli was measured by
radioimmunossay using commercially available kits (Yamasa,
Tokyo, Japan). Incorporation of 13'I was assessed as described
previously (Ambesi-Impionbato et al, 1980).
mRNA expression
Total RNA was extracted from FRTC tumours and FRTL-5 and
FRTC cells as described previously (Chomczynski and Sacchi,
1987). When cells were used, they were seeded in 100-mm Petri
dishes and cultured in 5H medium supplemented with 5% calf
serum. Some cells were stimulated with 10 U 1-1 TSH for 24 h. In
some experiments, total RNA was further purified with an oligo-
dT cellulose column (Pharmacia, Uppsala, Sweden). Expression of
various mRNAs was analysed by Northern blot hybridization
using 10gg oftotal RNA (forTg, TPO, cyclophilin and 3-actin) or
3 jig ofpoly-A RNA (forTg, TPO, TSH receptor, c-mvc, c-fos and
cyclophilin). Rat Tg cDNA (a gift from Dr DiLauro, European
Molecular Biology Laboratory in 1988), rat TPO cDNA (Dr
Rapoport, University ofCalifomnia, San Francisco, USA), rat TSH
receptor cDNA (Dr Akamizu, Kyoto University, Japan; Dr Kohn,
NIH, USA), ratcyclophilin cDNA (Dr Sutcliffe, Research Institute
of Scripps Clinic, La Jolla, USA), v-myc and v-fos (Japanese
Cancer Research Resources Bank) and f8-actin cDNA (Nippon
Gene, Tokyo, Japan) were used for hybridization. After the
transfer ofRNA, the membrane (Gene Screen Plus, Biotechnology
Systems, Boston, USA) was incubated at 42°C for 15 min in 2 x
standard saline citrate buffer (1 x SSC: 8.77 g sodium chloride,
4.41 g sodium citrate in 11 ofwater), followed by the addition ofa
labelled probe (T7 Quick Prime kit, Pharmacia). The final washing
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Figure 6 Expression of Tg, TPO and ,B-actin mRNA in FRTL-5 and
FRTC cells
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Figure 5 Effect of TSH on Tg production in FRTL-5 (L) an(
was with 0.1 x SSC at 60°C for 30 min forTg, TPO, TSH receptor,
cyclophilin and ,-actin mRNA expression, and 1 x SSC at 60°C
for 30 min for c-myc and c-fos mRNA. The membranes were then
exposed to Fuji X-ray film at -70°C with an intensifying screen.
Some membranes were also exposed to an imaging plate (Fuji
Film, Tokyo, Japan) and analysed by BAS2000 (Fuji Film). Probes
were removed from the membrane by boiling for 1 h in 0.1 x SSC,
1% sodium dodecyl sulphate (SDS). In some experiments, the
same membranes were used successively for the detection ofboth
specific and control (cyclophilin or ,-actin) mRNAs.
All experiments were carried out at least twice using different
batches ofthe cells ofthe same generation.
RESULTS
Transformation of FRTL-5 cells
Intraperitoneal transplantation of MDP-treated and untreated
FRTL-5 cells into Fisher rats was performed on three different
occasions. Disseminated intraperitoneal tumour formation with
massive bloody ascites was observed in ten out often rats injected
with MDP-treated FRTL-5 cells. Tumour formation was not
observed in six out of six rats injected with untreated FRTL-5
cells. Histological examination revealed that the tumours
consisted of atypical epithelial cells with irregular nuclei (Figure
IA). There was no histological difference in the tumours obtained
on these three different occasions. There were colloid-like struc-
tures (Figure 1B) filled with Tg-positive material (Figure 2A).
Figure 2B shows the thyroid follicles that were obtained from the
same rat as shown in Figure lB and stained with anti-Tg anti-
bodies. Neither this colloid-like material nor real colloid in the rat
thyroid was stained with antibodies to rat lymphocyte surface
antigens, such as OX6, OX8 or W3/25 (data not shown). The
tumour was digested and the cells were cultured in vitro. These
cells (FRTC) also formed large encapsulated tumours in Fisher
rats when transplanted subcutaneously (Figure 3). No tumour
formation was observed when FRTC cells were transplanted in
allogeneic Wistar rats. The doubling time of FRTC cells in vitro
was 19 h, and that of FRTL-5 cells was 30 h. Karyotype analysis
revealed that FRTC cells had 39-46 chromosomes with
103 104 detectable rearrangements (mode 42.9), while our FRTL-5 cells
had 37-40 chromosomes (mode 38.6). The original FRTL-5 cells
d FRTC (0) cells have been reported to have 41-42 chromosomes (Ambesi-
Impiombato et al, 1980).
in vitro effect of MDP
FRTL-5 cells (1 x 104 cells per well) were cultured in 5H or 6H
medium for 4 days in the presence of various amounts of MDP,
and [3H]TdR incorporation for 3 h was examined at the end ofthe
culture. In the absence of TSH, FRTL-5 cells did not proliferate
significantly in the presence ofMDP. In the presence ofTSH, cells
were about 80% confluent at the end of the culture. Even in the
presence of TSH, however, there was no significant difference in
[3H]TdR incorporation between MDP-treated and untreated
FRTL-5 cells (86-112% of the control in the presence of 10-5 to
101 g 1-' MDP). Similarly, cAMP production was not markedly
stimulated by MDP in FRTL-5 cells (85-114% of the control in
the presence of 15 to 10-' g 1-1 MDP). The morphology ofFRTL-
5 cells did not change even after long-term culture of up to 3
months in the presence ofMDP.
Response to various stimuli
FRTC cells produced cAMP in a dose-dependent manner after
TSH stimulation (Figure 4). However, [3H]TdR incorporation by
FRTC cells was not markedly enhanced by TSH (Table 1). IGF-l
(10 nmol 1-1) slightly enhanced the proliferation of FRTC cells,
although EGF (lOgg 1-1) did not (Table 2). The basal uptake of I'lI
into FRTC cells was low (1.4±0.2% of total radioactivity in 105
cells), and it was not enhanced by TSH stimulation (1.2±0.3%).
Large amounts of TSH stimulated FRTC cells to produce Tg
in vitro (Figure 5), although the response of Tg production to
TSH stimulation in FRTC cells was poor compared with that in
FRTL-5 cells.
mRNA expression
Thyroid-specific mRNAs were expressed in FRTC cells in vivo as
well as in vitro (Figure 6). Tg and TPO mRNAs were the same
size in FRTC and FRTL-5 cells. TSH receptor mRNA was
detected in FRTC cells in the presence and absence-of TSH, and
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Figure 7 Expression of TSH receptor mRNA in FRTL-5 and FRTC cells in
the presence or absence of TSH. TSH receptor mRNA in FRTL-5 cells
decreased after TSH stimulation for 24 h, but increased in FRTC cells. The
result is representative of three different experiments
c-myc
Cyclophilin
1 2 3 4
Figure 9 Expression of c-myc and cyclophilin mRNA in FRTC cells. Lanes
1,2 and 3 indicate c-myc and cyclophilin mRNA expression in FRTC cells
cultured in the absence or presence of TSH, and in the presence of MDP and
TSH, respectively. Lane 4 indicates c-myc and cyclophilin mRNA expression
in the FRTC tumour tissue
the size ofthe mRNA was the same in FRTL-5 cells. TSH receptor
mRNA levels in FRTC cells increased after the TSH stimulation
for 24 h, while levels decreased in FRTL-5 cells with TSH stimu-
lation (Figure 7). The expression of Tg mRNA decreased in the
tumour of FRTC of the 12th generation compared with that in the
tumour ofthe third generation (Figure 8). On the other hand, there
was no significant change in TSH receptor mRNA levels between
these tumours (Figure 8).
It is of interest that c-myc and c-fos mRNA were consistently
expressed in FRTC cells in vivo as well as in vitro. Expression of
these proto-oncogenes was more prominent in vivo than in vitro
(Figures 9 and 10). TSH did not enahnce the expression of c-myc
orc-fos in FRTC cells (Figures 9 and 10). The expression ofc-myc
in FRTL-5 cells was not enhanced by MDP stimulation for 4 days
(Figure 9).
DISCUSSION
There have been several reports on the transformation of FRTL-5
cells with virus and/or active oncogenes (Fusco et al, 1981, 1985,
1987; Ferrentino et al, 1984; Berlingieri et al, 1990), chemical
agents (Tramontano et al, 1986a; Sugawa et al, 1989) and the
Tg
TSH-R
Cyclophilin
3rd 12th
Figure 8 Expression of Tg, TSH receptor (TSH-R) and cyclophilin mRNA in
tumours of FRTC of the third and the 12th generation
c-fos
Cyclophilin
!~~~~~~~~~~~~~~~~~~~................
1 2 3
Figure 10 Expression of c-fos and cyclophilin mRNA in FRTC cells. c-fos
mRNA was expressed in FRTC cells cultured in the absence (lane 1) and in
the presence (lane 2) of TSH, or in the tumour tissue (lane 3)
human TSH receptor cDNA (Derwahl et al, 1992). We have gener-
ated amalignantly transformed cell line, FRTC, by thetransplanta-
tion of MDP-treated FRTL-5 cells into Fisher rats. All rats
transplanted with MDP-treated FRTL-5 cells developed tumours.
This result indicates that MDP may have a carcinogenic effect
similar to ethyl methane sulphonate, a chemical mutagenic agent,
which has been used to transform FRTL-5 cells (Tramontano et al,
1986a; Sugawa et al, 1989). However, MDP did not transform
FRTL-5 cells in vitro, and tumours did not develop after the
administration of MDP to Fisher rats (M litaka et al, unpublished
data). MDP, also referred to as an adjuvant peptide, has been
shown to stimulate T cells and macrophages (Ellouz et al, 1974;
Lefrancier et al, 1977; Specter et al, 1977). There have been no
previous reports concerning a possible carcinogenic effect ofMDP
on thyroid cells. We found that MDP had no stimulatory effect on
FRTL-5 cells in vitro in terms of [3H]TdR incorporation, cAMP
production or c-myc expression. Since untreated FRTL-5 cells did
not develop tumours, and the chromosomal heterogeneity and
rearrangements in FRTC were evident as assessed by the kary-
otype analysis, MDP must have acted as a carcinogen or a tumour-
promoting agent. Tramontano et al (1986) have found it necessary
to use chemical mutagenesis to isolate TSH-independent clones
from FRTL-5 cells because of the very low rate of spontaneous
mutational events. However, Endo et al (1990) have successfully
isolated a spontaneously transformed cell line from commercially
available FRTL cells. This discrepancy may be a result of the
difference ofthe cells. Similar to the previous report (Davies et al,
1987), our FRTL-5 cells also had the chromosomal heterogeneity.
Huber et al (1990) have reported that there is extreme individual
heterogeneity in human thyroid cells as well as FRTL-5 cells. They
concluded that each thyroid cell has a highly variable growth
programme, and non-transformed immortal cell lines in vitro may
represent one end of a spectrum of individual growth potential
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among normal thyrocytes. In addition to such a high growth poten-
tial, some in vivo growth factor(s) in Fisher rats might have
promoted the proliferation of transformed FRTL-5 cells in this
study. Previous studies by Wollman (1963) have shown that
thiouracil, a goitrogenic agent, promoted tumour formation of the
thyroid gland in rats. Others have also reported that propylth-
iouracil, an anti-thyroid drug, greatly increased the incidence of
thyroid tumour formation when rats were treated with N-bis(2-
hydroxypropyl) nitrosamine (Kitahori et al, 1982) or the Kirsten
murine sarcoma virus (Portella et al, 1989). As these goitrogenic
agents induce the elevation of serum TSH levels, TSH may act as
one of the tumour-promoting factors in those rats. Although the
precise mechanism for the generation of FRTC cells with MDP
treatment remains to be clarified, it is ofinterest that MDP, a ubiq-
uitously present bacterial wall peptide, may act as a tumour-
promoting or carcinogenic agent at least in some circumstances.
FRTC cells have several characteristics similar to FRTL-5 cells,
such as Tg production and the expression of Tg, TPO and TSH
receptor mRNA, although proliferation of FRTC cells was inde-
pendent of TSH. Previous reports have shown that transformed
FRTL-5 cells usually lose differentiation markers and TSH growth
dependence (Fusco et al, 1981; Sugawa et al, 1989; Berlingieri et
al, 1990). Wollman (1963) has also shown some tendency towards
progressive dedifferentiation among the more differentiated
thyroid tumours in rats. Differentiated human thyroid carcinomas,
however, express Tg, TPO and TSH receptor mRNA to varying
degrees (Brabant et al, 1991; Ohta et al, 1991). Similar to FRTL-5
cells and some ofpreviously reported mutant clones (Tramontano
et al, 1986a; Endo et al, 1990), FRTC cells produced cAMP and
Tg in a dose-dependent manner when stimulated with TSH.
Although this indicates that TSH may still continue to act as a
stimulator of Tg production in FRTC cells, the elevated basal Tg
levels and poor response of Tg to TSH stimulation also suggest
a possibility that FRTC may be able to produce Tg, at least in
part, independently of TSH. The discrepancy between TSH-
independent proliferation and TSH-dependent increase in cAMP
production in FRTC cells indicates that a signal transduction
pathway(s) other than the TSH-cAMP-mediated pathway may
primarily affect their growth. Although EGF may be a candidate
growth factor for thyroid cells (Roger and Dumont, 1982;
Westermark and Westermark, 1982), the proliferation of FRTC
cells was not markedly enhanced by EGF stimulation.
The histological patterns ofFRTC tumours exhibited consider-
able stability from generation to generation. However, the expres-
sion ofTg mRNA in the tumours ofthe 12th generation decreased
compared with those of the third generation, indicating that there
may be a tendency towards dedifferentition in FRTC. It is of
interest that there was no change in the expression of TSH
receptor mRNA between these tumours. This is compatible with
the previous report that TSH receptor mRNA expression is
retained much further along the pathway of transformation than
the expression of function-related genes, such as Tg or TPO
(Brabant et al, 1991).
It is of interest that the expression of TSH receptor mRNA
increased after TSH stimulation in FRTC cells, but decreased in
FRTL-5 cells, as reported previously (Akamizu et al, 1990). In
normal and abnormal human thyroid cells obtained from patients
with adenomas or papillary cancers, expression levels of TSH
receptor mRNA have been reported to increase after TSH stimula-
tion in vitro (Huber et al, 1991). Maenhaut et al (1992) reported
that TSH mRNA levels in dog thyrocytes increased after the TSH
stimulation for 20 h, but decreased afterwards. They also reported
that neither 2-day forskolin stimulation nor 6 h treatment with
TSH or forskolin in vitro had any influence on the TSH mRNA
expression in human thyroid cells. The basis of this discrepancy,
however, is unknown. In thyroid papillary or follicular carcinoma
tissues, TSH receptor mRNA levels have been reported to vary
from normal to markedly decreased (Brabant et al, 1991; Ohta et
al, 1991). TSH receptor mRNA levels were high in benign thyroid
tumours but not detectable in anaplastic cancers, indicating that
the expression of TSH receptor mRNA levels may be dependent
on the differentiation ofthyroid cells.
Proto-oncogenes, such as c-myc and c-fos, were expressed in
FRTC cells even in the absence of TSH stimulation. These proto-
oncogenes were expressed at higher levels in vivo than in vitro.
FRTL-5 cells have been reported to express these proto-oncogenes
for a brief period when stimulated with TSH or dibutyryl cAMP
(Colletta et al, 1986; Tramontano et al, 1986b), although others
have shown that EGF, but not TSH, stimulates the expression ofc-
fos and c-myc mRNA in primary porcine thyroid cell cultures
(Heldin and Westermark, 1988). In human thyroid cancer tissues,
it has been reported that c-myc or c-fos mRNA is expressed at
varying levels (Wyllie et al, 1989; Brabant et al, 1991). FRTC cells
persistently express c-myc or c-fos mRNA in vitro without TSH
stimulation. The persistent activation ofc-myc orc-fos may induce
unlimited proliferation ofFRTC cells in the absence ofTSH.
FRTC cells retain many characteristics of differentiated thyroid
cancer cells and are transplantable to syngeneic Fisher rats.
Although the mechanism of malignant transformation with MDP
remains unknown, FRTC may be a useful cell line for the investi-
gation ofdifferentiated thyroid cancer.
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